Cambridge Life Sciences is pleased to announce the beginning of a new distribution network with Zentech…

ELY, Cambridgeshire, June, 2006 - Cambridge Life Sciences is pleased to announce the beginning of a new distribution network with Zentech s.a, Belgium.

Zentech s.a signed a multi-year agreement with Cambridge Life Sciences’ to distribute the AUTOZYME™ product range in Belgium and other European countries through its existing distribution channels.

As a result, Zentech s.a will be adding to its current autoimmunity portfolio the following 96 wells microplate ELISA assays:

• AUTOZYME™ ACL (Anti Cardiolipin)
• AUTOZYME™ RF (Rheumatoid Factor)
• AUTOZYME™ nDNA (native DNA)
• AUTOZYME™ IFAB (Intrinsic Factor)

“We welcome Zentech’s decision to distribute Cambridge Life Sciences’ autoimmune product range in Europe. We strongly believe that Zentech’s distribution channels will further expand Cambridge Life Sciences existing presence in Europe. We hope to expand this distribution agreement to other countries in the near future.” said Peter Blake CEO of Cambridge Life Sciences Ltd. Mr. Blake also added that the two companies share similar vision, ethics and values; the similarity doesn’t stop there... This should benefit customers directly. We regard Zentech as a true partner and we are hoping to develop a reciprocal distribution arrangement to bring some of Zentech’s existing new developments to the UK market.

WORKSHOP ANNOUNCEMENT:
This launch of additional range of products is an opportunity for Zentech to cordially invite its European distributors and clients to participate at a one-day workshop that will be held in Zentech during the 3rd week of September. This training will be presented by Cambridge Life Sciences technical team specialists and will provide a clinical and technical overview of the AUTOZYME ELISA kits.

Should you be interested in taking part to this training workshop or would you need more information about the new products please contact us via the e-mail address: n.ruisseau@zentech.be.

We look forward to seeing you at the workshop.

About Cambridge Life Sciences Ltd.:
Cambridge Life Sciences is a ISO 9001:2000 and 13485:2003 certified biotechnology company specialised in the manufacturing of In Vitro diagnostic assays primarily for autoimmune diseases and the clinical chemistry market. All manufactured products are CE marked. Cambridge Life Sciences participates actively to the United Kingdom National External Quality Assessment Service (UK NEQAS) open to all UK laboratories offering a clinical service for analytes or investigations covered by the scheme. Cambridge Life Sciences research programmes are targeted at the development of new multiplexing technology in collaboration with both commercial and academic organisations.

About Zentech s.a.:
Biotechnology company specialized in diagnostic and treatment of immune system disorders.
With high skilled people, up-to-date technologies and facilities, ZenTech wants to:

• Reinforce its market position as major challenger in immune diseases diagnostic market.
• Valorise its immunoadsorption and protein engineering know-how providing innovative medical devices for extracorporal immunoadsorption and associated technologies aimed to treat refractory patients affected by auto-immune diseases
• Valorise its know-how in mimotope design and peptides use providing innovative treatment for immune tolerance induction-aimed to treat patients affected by auto-immune diseases.

ZenTech overall mission is to increase the value of shareholder's investment through sales growth, costs and accurate investment management and maintaining superior customer service and patient care.